| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/30/2001 | US20010018419 Isolated and purified; Rh antigens which can be immobilized and used in hematology, for isolation and purification of anti-Rh antibodies from solutions; useful in treatment of hemolytic disease of newborn |
| 08/30/2001 | US20010018415 Treating cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretion by administering Botulinum toxin type A |
| 08/30/2001 | US20010018414 Modified vitamin K-dependent polypeptides |
| 08/30/2001 | US20010018212 Molecular weight of 14,000 to 24,000 daltons; treating infectious diseases and malignant tumors with said protein |
| 08/30/2001 | US20010018211 Mutation suppresses apoptosis, permits cell proliferation; peptides including domain and nucleotides encoding domain useful for screening tumors for proliferative mutations |
| 08/30/2001 | US20010018208 Polynucleotide encoding polypeptide comprising fragment of mammalian aspartyl protease protein (Asp2) with beta-secretase activity; treatment of Alzheimer's disease |
| 08/30/2001 | US20010018204 Administering composition of tissure factor pathway inhibitor, homolog or active fragment with anti-proliferative activity; treating angiogenesis related diseases; cancer; arthritis; macular degeneration; diabetic retinopathy |
| 08/30/2001 | US20010018200 Genetic engineering; using a glycosylated thiosulfonate |
| 08/30/2001 | US20010018199 Process for preparing a desired protein |
| 08/30/2001 | US20010018198 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 08/30/2001 | US20010018193 Epitopes; medical diagnosis |
| 08/30/2001 | US20010018191 Immunology complex with epitopes; Alzheimer's disease |
| 08/30/2001 | US20010018189 Crohn's disease, skin disorders, antiallergens |
| 08/30/2001 | US20010018188 Synthetic peptides for the detection of trimethylamine (TMA) and their detection method and device |
| 08/30/2001 | US20010018058 Isolated polypeptide comprising an immunogenic portion of a breast protein comprising an amino acid sequence encoded by a polynucleotide |
| 08/30/2001 | US20010018056 Administering intranasally an antigen which is a non-toxic double mutant form of pertussis toxin inducing an immune response |
| 08/30/2001 | US20010018055 Safe, effectives vaccines for cattle, sheep and goats |
| 08/30/2001 | US20010018051 Inhibition of allograft and concordant xenograft rejection |
| 08/30/2001 | US20010018048 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors |
| 08/30/2001 | US20010017431 Bioriented polyethylene film with a high water vapor transmission rate |
| 08/30/2001 | CA2418496A1 Secretory polypeptides and corresponding polynucleotides |
| 08/30/2001 | CA2401868A1 Molecules for diagnostics and therapeutics |
| 08/30/2001 | CA2401623A1 Methods and compositions for identifying a protease |
| 08/30/2001 | CA2401367A1 Activated vitronectin as a marker of angiogenesis detected with phage antibodies |
| 08/30/2001 | CA2401256A1 A process for constructing dna based molecular marker for enabling selection of drought and diseases resistant germplasm screening |
| 08/30/2001 | CA2401219A1 Vertebrate globin |
| 08/30/2001 | CA2401195A1 Pai-2 conjugates for the treatment and imaging of cancer |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2401076A1 Molecules for disease detection and treatment |
| 08/30/2001 | CA2401070A1 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 08/30/2001 | CA2401031A1 Tlp peptides and dna sequences coding the same |
| 08/30/2001 | CA2400948A1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins |
| 08/30/2001 | CA2400915A1 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | CA2400896A1 Novel compositions and uses of dictyostatin compounds |
| 08/30/2001 | CA2400876A1 Novel protein and gene encoding the protein |
| 08/30/2001 | CA2400863A1 Staphylococcal gtpase obg nucleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | CA2400842A1 Novel compounds |
| 08/30/2001 | CA2400838A1 Novel method for down-regulation of amyloid |
| 08/30/2001 | CA2400831A1 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | CA2400823A1 Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity |
| 08/30/2001 | CA2400794A1 New transcription factor carp-2 |
| 08/30/2001 | CA2400661A1 Novel antibody with specificity for colon cancer |
| 08/30/2001 | CA2400642A1 Modified fluorescent proteins |
| 08/30/2001 | CA2400544A1 Method of modulating glycosylation pathways |
| 08/30/2001 | CA2400292A1 Production of mammals which produce progeny of a single sex |
| 08/30/2001 | CA2400040A1 Integrin antagonists |
| 08/30/2001 | CA2399999A1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | CA2399020A1 Process of purification of hcg and recombinant hcg purified by that method |
| 08/30/2001 | CA2398275A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | CA2397705A1 Compounds related to or derived from gfr.alpha.4 and their use |
| 08/29/2001 | EP1127944A1 Method for screening compound inhibiting signal transduction of inflammatory cytokine |
| 08/29/2001 | EP1127943A2 Means and methods for the expression of homologous and heterologous proteins in strains of Rhodococcus |
| 08/29/2001 | EP1127941A1 Novel dna fragment elevating gene expression dose |
| 08/29/2001 | EP1127894A1 Method of diagnosis of transmissible spongiform encephalopathy (TSE) |
| 08/29/2001 | EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/29/2001 | EP1127578A1 Remedies for bone metabolic errors |
| 08/29/2001 | EP1127577A2 Ligand for the c-kit receptor and methods of use thereof |
| 08/29/2001 | EP1127259A2 Thromboplastin reagents and methods for preparing and using such reagents |
| 08/29/2001 | EP1127170A1 Human pan-hcv human monoclonal antibodies |
| 08/29/2001 | EP1127155A1 Enzymatic amidation of peptides |
| 08/29/2001 | EP1127150A2 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 08/29/2001 | EP1127149A2 Cells for the production of helper dependent adenoviral vectors |
| 08/29/2001 | EP1127147A2 Plant proteins that interact with nuclear matrix proteins and function as transcriptional activators |
| 08/29/2001 | EP1127146A2 Novel expression cassette for expressing genes in plant seed |
| 08/29/2001 | EP1127145A2 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(AGROBACTERIUM VITIS) |
| 08/29/2001 | EP1127143A2 Dna comprising rice anther-specific gene and transgenic plant transformed therewith |
| 08/29/2001 | EP1127140A2 Fk506-based regulation of biological events |
| 08/29/2001 | EP1127136A1 Delivery of superoxide dismutase to neuronal cells |
| 08/29/2001 | EP1127134A1 Rotavirus subunit vaccine |
| 08/29/2001 | EP1127133A2 Polypeptide mediating cell permeability |
| 08/29/2001 | EP1127132A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 08/29/2001 | EP1127131A2 Connective tissue growth factor (ctgf) and methods of use |
| 08/29/2001 | EP1127129A1 Myosin heavy chain homolog |
| 08/29/2001 | EP1127128A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 08/29/2001 | EP1127127A1 Regulator of notch signaling activity |
| 08/29/2001 | EP1127126A1 G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof |
| 08/29/2001 | EP1127125A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 08/29/2001 | EP1127124A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/29/2001 | EP1127123A2 Cell surface glycoproteins |
| 08/29/2001 | EP1127122A2 Growth factor related molecules |
| 08/29/2001 | EP1127121A2 Construction of retrovirus with the streptomyces mel locus expressible in mammalian cells |
| 08/29/2001 | EP1127120A1 Genomic and complete cdna sequences of human adipocyte-specific apm1 and biallelic markers thereof |
| 08/29/2001 | EP1127119A1 Compounds and methods for modulating claudin-mediated functions |
| 08/29/2001 | EP1127118A1 Human gs protein regulator gene |
| 08/29/2001 | EP1127117A1 Opg fusion protein compositions and methods |
| 08/29/2001 | EP1127113A2 Transgenic and cloned mammals |
| 08/29/2001 | EP1127112A2 Methods for cloning animals |
| 08/29/2001 | EP1127110A1 Modified exosomes and uses |
| 08/29/2001 | EP1127104A1 Method for the massive culture of cells producing recombinant human erythropoietin |
| 08/29/2001 | EP1127076A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 08/29/2001 | EP1127075A2 A method of treating tumors using fas-induced apoptosis |
| 08/29/2001 | EP1127074A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 08/29/2001 | EP1127073A1 Human potassium channel (h-traak) |
| 08/29/2001 | EP1127072A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 08/29/2001 | EP1127070A2 $i(IKAROS) ISOFORMS AND MUTANTS |
| 08/29/2001 | EP1127069A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
| 08/29/2001 | EP1127068A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 08/29/2001 | EP1127067A2 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 08/29/2001 | EP1127066A1 Modified proteins |
| 08/29/2001 | EP1127065A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |